Sales & Marketing One year later, EVERSANA plans to go beyond the AI agency At an event in New York City, EVERSANA shared updates, customer perspectives, and future plans for its AI agency, which is moving beyond that mandate.
News Lundbeck taps EVERSANA’s AI Agency for commercialisation In advance of its NYC event, EVERSANA announces expanded AI agency capabilities and a partnership with brain health giant Lundbeck.
Market Access A dynamic moment for pharma pricing: Insights from PPIC At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.
News Jen Norton appointed market access leader at EVERSANA EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.
News Mike Guarino appointed to lead EVERSANA INTOUCH Life sciences service provider EVERSANA has named industry veteran Mike Guarino to lead its global health agency EVERSANA INTOUCH.
Press Releases Partner Content Xcovery Partners with EVERSANA to Commercialize Lung Cancer ... EVERSANA will provide comprehensive end-to-end commercialization services for Xcovery
News RNAi biotech City hauls in $200m in upsized IPO City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.